BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26758557)

  • 1. MACC1 Induces Tumor Progression in Transgenic Mice and Colorectal Cancer Patients via Increased Pluripotency Markers Nanog and Oct4.
    Lemos C; Hardt MS; Juneja M; Voss C; Förster S; Jerchow B; Haider W; Bläker H; Stein U
    Clin Cancer Res; 2016 Jun; 22(11):2812-24. PubMed ID: 26758557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 3. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of NANOG Mediates the Inhibitory Effect of Aspirin on Tumor Growth and Stemness in Colorectal Cancer.
    Wang H; Liu B; Wang J; Li J; Gong Y; Li S; Wang C; Cui B; Xue X; Yang M; Fan W; Kang Z; Kamran M; Xu J; Tian P; Luo Y; Hou Z; Dong L; Ren Y; Li M; Wen Q; Cheng W; Xu L; Wang L; Liu Q
    Cell Physiol Biochem; 2017; 44(3):1051-1063. PubMed ID: 29179207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
    Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
    Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.
    You L; Guo X; Huang Y
    Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanog, Oct4 and Tet1 interplay in establishing pluripotency.
    Olariu V; Lövkvist C; Sneppen K
    Sci Rep; 2016 May; 6():25438. PubMed ID: 27146218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
    Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
    J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling.
    Brown AR; Simmen RC; Raj VR; Van TT; MacLeod SL; Simmen FA
    Carcinogenesis; 2015 Sep; 36(9):946-55. PubMed ID: 26210742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MACC1 is related to colorectal cancer initiation and early-stage invasive growth.
    Ren B; Zakharov V; Yang Q; McMahon L; Yu J; Cao W
    Am J Clin Pathol; 2013 Nov; 140(5):701-7. PubMed ID: 24124150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions.
    Xiao L; Song Y; Huang W; Yang S; Fu J; Feng X; Zhou M
    Reprod Biol Endocrinol; 2017 Mar; 15(1):14. PubMed ID: 28253866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
    Lee S; Wottrich S; Bonavida B
    Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
    Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
    Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas.
    Rasti A; Mehrazma M; Madjd Z; Abolhasani M; Saeednejad Zanjani L; Asgari M
    Sci Rep; 2018 Aug; 8(1):11739. PubMed ID: 30082842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of intestinal tumor formation by deletion of the DNA methyltransferase 3a.
    Weis B; Schmidt J; Maamar H; Raj A; Lin H; Tóth C; Riedmann K; Raddatz G; Seitz HK; Ho AD; Lyko F; Linhart HG
    Oncogene; 2015 Apr; 34(14):1822-30. PubMed ID: 24837369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanog co-regulated by Nodal/Smad2 and Oct4 is required for pluripotency in developing mouse epiblast.
    Sun LT; Yamaguchi S; Hirano K; Ichisaka T; Kuroda T; Tada T
    Dev Biol; 2014 Aug; 392(2):182-92. PubMed ID: 24929238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.